ClinicalTrials.Veeva

Menu

International T1 Multicentre CMR Outcome Study (T1-CMR)

K

King's College London

Status

Completed

Conditions

Chronic Kidney Diseases
Coronary Artery Disease
Cardiomyopathy
Inflammation
Heart Failure
Fibrosis

Study type

Observational

Funder types

Other

Identifiers

NCT02407197
2011-T1-MC

Details and patient eligibility

About

Myocardial fibrosis is the fundamental substrate for the development of heart failure.

Cardiovascular magnetic resonance (CMR) allows non-invasive assessment of myocardial fibrosis based on late gadolinium enhancement (LGE) and T1 mapping.

Patients: Prospective longitudinal observational multicenter study of consecutive patients with suspected or known non-ischemic cardiomyopathy.

Imaging: Non-invasive measures of myocardial fibrosis: native T1, extracellular volume fraction (ECV) and LGE.

Primary endpoints: all cause and cardiovascular mortality.

Secondary endpoints: arrhythmic composite and HF composite endpoints.

Enrollment

1,629 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. adults > 18 years of age
  2. clinical indication for CMR
  3. able to provide informed consent

Exclusion criteria

contraindications for cardiac magnetic resonance imaging due to MR unsafe devices or objects

Trial contacts and locations

4

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems